Allelic imbalance in mammary carcinomas induced by either 7,12‐dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis

To identify and compare the genetic lesions associated with tumorigenesis in rats carrying the mammary carcinoma suppressor (MCS) 1 gene, we induced mammary carcinomas in (Wistar Furth (WF) × Copenhagen (Cop))F1 rats by using either 7,12‐dimethylbenz[a]anthracene (DMBA) or radiation. The tumors were screened for allelic imbalances by using polymerase chain reaction and 65 polymorphic microsatellite markers spanning the genome. No allelic imbalance was detected at the mapped location of MCS‐1 on chromosome 2; however, a scan of the genome revealed random allelic imbalances in the radiation‐induced tumors. In addition, non‐random loss of heterozygosity (LOH) on chromosome 1 in the DMBA‐induced tumors was documented. We then screened three other subsets of DMBA‐ and radiation‐induced mammary carcinomas from (WF × Fischer (F344))F1, (Wistar Kyoto×F344)F1, and (F344×Cop)F1 rats for imbalance on chromosomes 1 and 2. No allelic imbalance was detected in the MCS‐1 region of chromosome 2 in any of the tumors screened. Nonrandom imbalance on chromosome 1 was detected but only in the DMBA‐induced tumors from the (F344×Cop)F1 rats. Thus, only Cop‐derived F1 rats have mammary tumors with the chromosome 1 imbalance; however, the imbalance does not favor the Cop parental allele. We also analyzed the DMBA‐induced tumors with LOH at chromosome 1 for Ha‐ras codon 61 mutation and found no association. These results suggest that loss of the MCS‐1 Cop allele is not required for tumor formation, that the genetic background of the F1 rat appears to influence the type of genetic lesion identified in the mammary tumors, and that there is no association between Ha‐ras codon 61 mutation and chromosome 1 imbalance in our model system. © 1996 Wiley‐Liss, Inc.

[1]  Y. Hosoya,et al.  Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine , 1996, Molecular carcinogenesis.

[2]  R Rothstein,et al.  A high-resolution annotated physical map of the human chromosome 13q12-13 region containing the breast cancer susceptibility locus BRCA2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[4]  K. McKenzie,et al.  Animal models for breast cancer. , 1995, Mutation research.

[5]  N. Phillips,et al.  Allelic loss and the progression of breast cancer. , 1995, Cancer research.

[6]  M. Gariboldi,et al.  Analysis of loss of heterozygosity in murine hepatocellular tumors , 1995, Molecular carcinogenesis.

[7]  G. Hampton,et al.  Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. , 1995, Cancer research.

[8]  H. Lehrach,et al.  Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Kominami,et al.  Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine‐induced C3H/MSM mouse hepatocellular carcinomas in culture , 1995, Molecular carcinogenesis.

[10]  L. Gollahon,et al.  Loss of heterozygosity at chromosome 1q loci in rat mammary tumors , 1995, Molecular carcinogenesis.

[11]  M. Daly,et al.  A genetic linkage map of the laboratory rat, Rattus norvegicus , 1995, Nature Genetics.

[12]  E. Lander,et al.  Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. , 1994, Cancer research.

[13]  Francis S. Collins,et al.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.

[14]  Patrick Dowd,et al.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.

[15]  F. Hendler,et al.  Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. , 1994, Cancer research.

[16]  M. Cohen.  Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: implications for hemihyperplasia, associated neoplasms, and overgrowth. , 1994, American journal of medical genetics.

[17]  R. Elliott,et al.  Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. , 1994, Carcinogenesis.

[18]  E. Lander,et al.  Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. , 1994, Cancer research.

[19]  E. Lander,et al.  Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Gould,et al.  Cloning and characterization of overexpressed genes in the mammary gland of rat strains carrying the mammary carcinoma suppressor (Mcs) gene. , 1993, Cancer research.

[21]  Benjamin Tycko,et al.  Tumour-suppressor activity of H19 RNA , 1993, Nature.

[22]  M. Newton,et al.  Mammary carcinoma suppressor and susceptibility genes in the Wistar-Kyoto rat. , 1992, Carcinogenesis.

[23]  L. Gollahon,et al.  Chromosomal localization of the rat Harvey-ras-1 gene (HRAS) by in situ hybridization. , 1992, Cytogenetics and cell genetics.

[24]  M. Gould,et al.  Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. , 1990, Cancer research.

[25]  A. Balmain,et al.  Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.

[26]  J. Isaacs.  Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. , 1986, Cancer research.

[27]  M. Gould.  Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. , 1986, Cancer research.

[28]  A. Knudson,et al.  Genetics of human cancer. , 1986, Annual review of genetics.

[29]  M. A. Tanner,et al.  Irradiation and prolactin effects on rat mammary carcinogenesis: intrasplenic pituitary and estrone capsule implants. , 1985, Journal of the National Cancer Institute.

[30]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .